Institutional investors purchased a net $2.6 million shares of IRWD during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 107.32% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 92.0 Thousand shares of Ironwood Pharmaceuticals ...
MIZUHO SECURITIES USA, INC. Bought 32.5 Thousand shares of Ironwood Pharmaceuticals ...